The present disclosure generally relates to catheter assemblies that are delivered to end users in a ready-to-use condition, and more particularly, to such a catheter assembly that is vapor hydrated and a method of making a vapor hydrated catheter assembly.
It is generally well known that there are two distinct types of intermittent urinary catheters typically used by those who are able to do so without the assistance of a healthcare professional. These catheters include lubricated catheters which utilize a gel that is applied to the outer surface of the catheter tube prior to insertion into the urethra and hydrophilic catheters wherein a hydrophilic coating on the catheter tube is activated prior to use by treatment with a liquid such as water or saline solution. In the case of hydrophilic catheters, the liquid which is utilized to treat the hydrophilic coating must be provided by the manufacturer if the catheter is to be delivered to an end user in a ready-to-use condition.
As a result, it is necessary for the hydrophilic coating to either be activated at a point in time just prior to placing the catheter in a package or after placing it in a package. The more common approach is to place the hydrophilic coated catheter in a package together with the liquid. In particular, the liquid for activating the hydrophilic coating on the catheter has typically been placed loosely within the package or it has been in a container placed within the package.
With regard to placing the liquid loosely within the package, this has been found to be an undesirable approach because it presents a spill hazard. The loose liquid is typically provided in a reasonably significant quantity to ensure that there will be sufficient liquid remaining through a commercially viable shelf life to maintain the hydrophilic coating in an activated condition. However, since it is necessary to provide a reasonably significant quantity of the liquid to ensure there will be direct contact of the liquid with the hydrophilic coating following assembly, the liquid can easily spill from the package when the package is opened and may thereby wet and/or stain the end user's clothing. In addition, there is a serious technical problem which relates to the condition in which such a ready-to-use hydrophilic catheter must be sterilized.
Specifically, the sterilization process must take place after the catheter and loose liquid have been sealed within the package. Thus, the catheter is sterilized when the hydrophilic coating is wet, i.e., after it already has been activated by the liquid. However, a wet hydrophilic coating may degrade upon sterilization using conventional techniques, e.g., radiation. In particular, the wet hydrophilic coating may detach from the catheter tube resulting in a bumpy, high coefficient of friction surface.
To avoid such sterilization problems, some manufacturers place a liquid container within the package. According to this arrangement, the end user is provided with instructions to rupture or otherwise open the liquid container to permit the liquid to be released within the package so it can activate the hydrophilic coating. The liquid can be provided in a more limited quantity since the user can be instructed to manipulate the package for a period of time to ensure direct contact of the liquid with the hydrophilic coating immediately prior to use. The technical problem of degradation of a wet hydrophilic coating during sterilization is avoided because the liquid is confined to the liquid container during sterilization which means the hydrophilic coating is in a dry state at time of sterilization. However, there are still drawbacks because the catheter is not in a ready-to-use condition when it reaches the end user since the hydrophilic coating requires activation by rupturing/opening the liquid container and manipulating the package.
There is the continuing presence of a spill hazard even though the liquid may be provided in a more limited quantity. The liquid will be contained loosely within the package interior space holding the catheter after the liquid container has been ruptured to release the liquid so it can easily spill on the end user when the package is opened to remove the catheter. In addition, the presence of the liquid can wet the hands of the end user making it more difficult and messy to handle the catheter.
As noted above, hydrophilic coated catheters typically are provided with a thin hydrophilic coating adhered to the outer surface of the catheter for activation by direct contact with a liquid. When the hydrophilic coating is activated by contact with a hydrating liquid such as water, it provides an extremely low coefficient of friction surface. Whether the hydrating liquid is brought into direct contact with the hydrophilic coating by the manufacturer or the end user, it is generally recognized that it takes around 30 seconds to activate the coating.
In all of these existing products, the catheter therefore depends upon direct contact of the liquid swelling medium (e.g., liquid water) with the entirety of the hydrophilic coated catheter surface for a period of time typically recognized as being 30 seconds. Moreover, all of these existing products achieve direct liquid water contact by providing a package for the catheter that permits liquid water to flow freely within the catheter-containing cavity of the package, and permits unobstructed access of the liquid water to the catheter surface for direct contact therewith. Because of the free flow of loose liquid water within the package and unobstructed access to the catheter surface, it is easy to ensure direct contact of the liquid swelling medium with the entire surface of the catheter that has been treated with the hydrophilic coating.
However, it has remained a technical challenge to provide a urinary catheter which has a hydrophilic coating where the catheter meets all of the important criteria for such a product from the perspective of both the manufacturer and the end user, including the ability to sterilize the catheter without degrading the hydrophilic coating due to wetting prior to sterilization or exposing the end user to a spillage hazard from the liquid water which has been placed in direct contact with the hydrophilic coating.
Accordingly, the present disclosure is generally directed to a catheter assembly comprising a catheter having a hydrophilic coating on at least a part of its length intended to produce a low-friction surface on the catheter when treated with a hydrating substance. The catheter assembly also includes a catheter package forming an interior space divided by a gas permeable, liquid impermeable barrier into first and second distinct and separate cavities. The first cavity accommodates the catheter therein and the second cavity accommodates at least liquid phase water or an aqueous liquid therein. In this regard, the liquid phase water or aqueous liquid therein is capable of changing phase inside the second cavity from a liquid to a vapor which is then available to activate the hydrophilic coating on the catheter.
In its liquid phase, the water or aqueous liquid is confined to the second cavity because of the gas permeable, liquid impermeable barrier dividing the interior space into the two cavities is liquid impermeable. Thus, if the liquid water or aqueous liquid did not undergo a phase change from a liquid to a vapor within the second cavity, the hydrophilic coating on the catheter would not be hydrated. However, after the liquid water or aqueous liquid undergoes a phase change from a liquid to a vapor, the vapor in the second cavity is capable of passing from the second cavity, through the gas permeable, liquid impermeable barrier, into the first cavity.
In the first cavity, the vapor serves as the hydrating substance for the hydrophilic coating, and the vapor is capable of reaching the first cavity because the gas permeable, liquid impermeable barrier dividing the package interior space into two distinct and separate cavities is gas permeable. Therefore, after a phase change, the hydrophilic coating on the catheter will be hydrated by the vapor resulting from the phase change. In other words, the vapor generated by the phase change of the liquid in the second cavity is capable of passing from the second cavity, through the gas permeable, liquid impermeable barrier, into the first cavity to cause the hydrophilic coating on the catheter to be hydrated.
By this arrangement, it is possible to produce the low-friction surface on the catheter so it is in a fully ready-to-use condition when the catheter reaches the end user.
As will be appreciated, the liquid in the second cavity remains a liquid until some or all of it undergoes a phase change to become a vapor. To the extent the liquid changes phase in the second cavity, it will be understood that there will be less liquid remaining in the second cavity, but at no time does liquid ever pass directly from the second cavity into the first cavity because of the gas permeable, liquid impermeable barrier. Accordingly, liquid contained in the second cavity can never directly contact the hydrophilic coating, and it can never directly hydrate the hydrophilic coating; only vapor resulting from a phase change can do that.
While the vapor which passes from the second cavity, through the gas permeable, liquid impermeable barrier, into the first cavity may undergo some condensation within the first cavity, liquid droplets in the first cavity resulting from such condensation will comprise a de minimis amount of liquid far less than would be required to produce liquid hydration of the hydrophilic coating on the catheter.
Preferably, the catheter package forming the interior space is made of a single gas impermeable rectangular sheet, with opposite edges joined by a single longitudinal seal and having an end seal at each of opposite ends thereof. It may alternatively be formed of a gas impermeable material comprised of two confronting rectangular sheets joined by a seal extending entirely about the perimeters of the sheets. Further, the catheter assembly advantageously includes a wicking material within the second cavity. A rupturable container may be provided for selective liquid flow communication with the wicking material.
In one exemplary embodiment, a rupturable container may be provided within the catheter package for selective liquid flow communication with the second cavity in spaced relation to the wicking material. In another exemplary embodiment, the rupturable container may include a rupturable compartment within the catheter package in spaced relation to the wicking material for selective liquid flow communication with the wicking material through a rupturable seal.
From the foregoing, it will be appreciated that the hydrating substance for activating the hydrophilic coating on the urinary catheter comprises water vapor, or vapor phase water. The vapor which is used to activate the hydrophilic coating results from a phase change of water from liquid water to water vapor in the second cavity of the catheter package space.
In another respect, the present disclosure is directed to a method of making a ready-to-use catheter assembly comprising the step of providing a catheter package having an interior space divided by a gas permeable, liquid impermeable barrier into a first cavity and a second cavity. The method also includes the steps of placing a catheter having a hydrophilic coating on at least a part of its length into the first cavity and placing liquid into the catheter package so as to be in liquid isolation relative to the first cavity. Still additionally, the method further includes the step of placing the liquid directly into, or for selective liquid flow communication with, the second cavity of the catheter package and also includes the step of sealing the catheter package such that the catheter is disposed within the first cavity.
In addition, in accordance with another aspect of the disclosure, the method may include the step of delaying distribution or use of the catheter assembly for a period of time sufficient for one or more of several things to occur. In particular, distribution or use may be delayed for a time sufficient for i) the liquid to be placed either directly into, or in selective liquid flow communication with, the second cavity, ii) at least some of the liquid to change phase to vapor within the second cavity, iii) at least some of the vapor to pass from the second cavity, through the gas permeable, liquid impermeable barrier, and into the first cavity, and/or iv) the vapor in the first cavity to hydrate the hydrophilic coating to produce a low-friction surface on the catheter, whereby the catheter assembly is ready-to-use. Furthermore, the method may advantageously include the step of providing the liquid in a rupturable container.
More specifically, the liquid may be provided in a rupturable container which is in communication with the second cavity. The method then may advantageously include the step of providing a wicking material within the second cavity in order to absorb the liquid after the rupturable container has been breached. In this manner, the wicking material can absorb and distribute the liquid so at least a portion of it can thereafter undergo a phase change to change to vapor within the second cavity. The vapor migrates through the vapor permeable, liquid impermeable barrier into the first cavity where it hydrates the hydrophilic coating on the catheter.
As will be appreciated, liquid is always confined to the second cavity because the barrier dividing the interior space of the catheter package into first and second cavities is liquid impermeable. Accordingly, the hydrophilic coating on the catheter in the first cavity cannot be hydrated until at least a portion of the liquid undergoes a phase change to change to vapor. However, once there is vapor present in the second cavity as a result of the phase change, vapor can pass through the barrier into the first cavity to hydrate the hydrophilic coating because the barrier is gas permeable.
One exemplary method includes the steps of forming the catheter package to have a generally elongated rectangular shape and providing the liquid in a rupturable container within the second cavity in spaced relation to one end of the catheter. The method may then advantageously include the step of placing a wicking material in the second cavity to extend longitudinally generally coextensive with the catheter in the first cavity and the wicking material having an end thereof positioned in proximity to the rupturable container. The method may then also advantageously include the step of providing a seal extending inwardly from each side of the catheter package between the catheter and the rupturable container to form a passageway for the liquid to pass to the end of the wicking material.
Another exemplary method includes the steps of forming the catheter package to have a generally elongated rectangular shape and providing the liquid in a rupturable compartment of the catheter package for selective liquid flow communication with the second cavity. The method may then advantageously include the steps of forming the rupturable compartment by providing a rupturable seal and placing a wicking material in the second cavity so as to be longitudinally generally coextensive with the catheter in the first cavity. The method may then also advantageously include the wicking material being positioned in the second cavity for selective liquid flow communication with the rupturable compartment after the rupturable seal is breached and the wicking material having an end in proximity to the rupturable seal.
In the last-mentioned exemplary method, it may further advantageously include the step of forming an intermediate seal across the catheter package between the rupturable seal and the catheter so as to extend across the wicking material to form an intermediate compartment to thereby define a liquid-receiving space.
In both of these exemplary methods, the catheter and the liquid are sterilized after the catheter package has been sealed but before the liquid has been released for absorption by the wicking material. Another feature of the exemplary methods is to sever the catheter package between the catheter and the rupturable container for the liquid after releasing the liquid. Still another feature of the exemplary methods is to thereafter form an end seal for the catheter package so that it is fully sealed for shipment to an end-user in a ready-to-use condition.
A further exemplary method includes the steps of forming the catheter package to have a generally elongated rectangular shape and placing the liquid directly into the second cavity in liquid isolation relative to the catheter. The method may then advantageously include the step of placing a wicking material in the second cavity to extend longitudinally generally coextensive with the catheter in the first cavity. The method may then also advantageously include the step of providing a gas permeable, liquid impermeable barrier within the package interior space to define the first and second cavities and to maintain the liquid out of direct contact with the hydrophilic coated catheter.
In this exemplary method, the catheter and the liquid are sterilized after the catheter package has been sealed. This can be done at the end of the assembly line shortly after the catheter package has been sealed and little or no liquid has vaporized or, by selecting a material for the gas permeable, liquid impermeable barrier having a relatively low gas permeability, sterilization can be done within a few days thereafter. Since, at the time of sterilization, the hydrophilic coating will not have been substantially hydrated by vapor in either instance, the sterilization will not cause the coating to degrade.
Other objects, advantages, and features of the present disclosure will become apparent from a consideration of the following specification taken in conjunction with the accompanying drawings.
In the illustrations given herein, and with reference first to
The liquid 30 is confined within the second cavity 26b because of the liquid impermeable nature of the gas permeable, liquid impermeable barrier 28 which may be configured as a mid-package film or membrane. This film or membrane physically divides the interior space 26 into the two cavities 26a and 26b such that the hydrophilic coating cannot be activated or hydrated until at least a portion of the quantity of vapor donating liquid 30 in its liquid phase undergoes a phase change from a liquid to a vapor. However, after the liquid 30 does undergo a phase change from a liquid to a vapor, the vapor in the second cavity 26b is then capable of passing from the second cavity 26b, through the gas permeable, liquid impermeable barrier 28, and into the first cavity 26a to serve as the activating or hydrating substance.
In the embodiment illustrated in
As will be appreciated from the foregoing description, both of the embodiments shown in
Referring to
The wicking material 36 within the second cavity 26b extends longitudinally so as to be generally coextensive with the catheter 22 in the first cavity 26a. An end 36a of the wicking material 36 is preferably positioned in spaced relation but in proximity to the rupturable container 40. The catheter package 24 includes seals 42a and 42b extending inwardly from each side of the package between the catheter 22 and the rupturable container 40 to form a passageway as at 44 for the liquid 30 to pass from the rupturable container 40, after it has ruptured, to the end 36a of the wicking material 36.
While not specifically shown, it will be appreciated that the structural features as well as the details of construction of the catheter assembly 20′ in the embodiment of
Referring now to
The liquid 130 is within a rupturable compartment 146 within the catheter package 124 in spaced relation to the wicking material 136 for selective liquid flow communication with the wicking material 136 through a rupturable seal 148. The wicking material 136 is within the second cavity 126b of the interior space 126 for selective liquid flow communication with the rupturable compartment 146 within the catheter package 124 containing the liquid 130 after the rupturable seal 148 is breached. The liquid 130 absorbed by the wicking material 136 is capable of undergoing a phase change from a liquid to a vapor. After the liquid 130 undergoes a phase change, the vapor resulting from the phase change passes from the second cavity 126b, through the gas permeable, liquid impermeable barrier 128, and into the first cavity 126a to hydrate the hydrophilic coating to produce the low-friction surface on the catheter 122.
As with the embodiment illustrated in
With regard to the respective embodiments of
However, the gas permeable, liquid impermeable barrier 128 in the embodiment of
Referring to
When this alternative embodiment is utilized, the gas permeable, liquid impermeable barrier 128′ will be seen to comprise a mid-package film or membrane which cooperates with the rectangular sheets 124a′, 124b′ and the various seals to divide the interior space 126′ into a first cavity 126a′ and a second cavity 126b′ such that the catheter 122′ is accommodated in the first cavity 126a′ of the interior space 126′ and the wicking material 136′ is disposed within the second cavity 126b′. As before, the liquid 130 is in a separate compartment such as the rupturable compartment 146 which is in liquid flow communication with the second cavity 126b′ and, thus, with the wicking material 136′ when the rupturable seal 148 is breached so that the liquid 130 can reach the end 136a of the wicking material 136′ (as seen in
In both of the embodiments which are illustrated in
With regard to the embodiment illustrated in
When a single sheet of material is used to form a package such as 24′ in
As shown in
Still referring to
The sleeve 122a may advantageously cover the entire hydrophilic coated portion of the catheter to make it possible for the end user to avoid making contact with the portion of the catheter which is intended to be inserted into the urethra to thereby prevent or limit the possibility of urinary tract infections.
In contrast to the embodiment illustrated in
More specifically, the resulting product will resemble
In all of the foregoing embodiments, both the catheter 22, 22′, 122, 122′ and the wicking material 36, 36′, 136, 136′ are disposed in a catheter package 24, 24′, 124, 124′ of a generally elongated rectangular shape. The catheter 22, 22′, 122, 122′ and at least a major portion of the wicking material 36, 36′, 136, 136′ are also disposed between seals 42a and 42b, or between intermediate seal 150 and the end seal 32d or 132d. The foregoing features will be appreciated by referring to
Before describing the method, it will also be noted in all embodiments that each of the respective catheter packages 24, 24′, 124, 124′ has a tear tape 56, 56′, 156, 156′ which may be adhesively affixed to the inner surface of the sheet material forming the catheter package 24, 24′, 124, 124′. The tear tape 56, 56′, 156, 156′ is affixed such that it is positioned along one side edge of the catheter package 24, 24′, 124, 124′ within the first sealed cavity 26a, 26a′, 126a, 126a′. In addition, each of the respective catheter packages 24, 24′, 124, 124′ may include a v-notch such as 58 (
When the end user opens the package by using the tear tape 56, 56′, 156, 156′, the tear tape 56, 56′, 156, 156′ will be understood to cause the catheter package 24, 24′, 124, 124′ to tear along it to thereby cause the catheter package 24, 24′, 124, 124′ to open along an intended opening line for access to the catheter 22, 22′, 122, 122′ in the first sealed cavity 26a, 26a′, 126a, 126a′ without opening the second sealed cavity 26b, 26b′, 126b, 126b′. The tear tape 56, 56′, 156, 156′ thus extends within the first sealed cavity 26a, 26a′, 126a, 126a′ in a desired direction relative to the catheter 22, 22′, 122, 122′ to cause the package 24, 24′, 124, 124′ to open along the intended opening line in a manner facilitating removal of the catheter from the package for use without opening the second sealed cavity 26b, 26b′, 126b, 126b′. Thus, residual liquid still present in the second cavity 26b, 26b′, 126b, 126b′ that has not changed phase into vapor is safely confined to the second cavity 26b, 26b′, 126b, 126b′ and cannot spill on the end user. The tear tape 56, 56′, 156, 156′ can advantageously be adhesively or otherwise affixed to an inner surface of the catheter package 24, 24′, 124, 124′ within the first sealed cavity 26a, 26a′, 126a, 126a′ so as to extend generally from one end of the catheter package to the other end thereof in a manner whereby it will be generally parallel to the catheter 22, 22′, 122, 122′.
When the end user opens the catheter package 24, 24′, 124, 124′, less of the original liquid 30, 130 will be present in the second cavity 26b, 26b′, 126b, 126b′ as compared to the time of manufacture, because some of it will have changed phase to a vapor. However, for the liquid 30, 130 which does remain, it is safely confined in the second cavity 26b, 26b′, 126b, 126b′. By taking advantage of vapor hydration of the hydrophilic coating and isolating the liquid 30, 130 in a cavity that remains sealed even after removing the catheter 22, 22′, 122, 122′ from the catheter package 24, 24′, 124, 124′, there is no possibility of spillage.
While the vapor which passes from the second cavity 26b, 26b′, 126b, 126b′, through the gas permeable, liquid impermeable barrier 28, 28′, 128, 128′, into the first cavity 26a, 26a′, 126a, 126a′ may undergo some observable condensation within the first cavity, the liquid droplets which may be found in the first cavity resulting from such condensation will comprise, at most, a de minimis amount of liquid which will be far less than what would be required to produce liquid hydration of the hydrophilic coating on the catheter 22, 22′, 122, 122′ and far less than what could possibly cause a spillage hazard. Some of this condensation may occur at a water activity below unity, due to the presence of surfaces and small spaces within the package, and may not be thermodynamically driven to enter the hydrophilic coating. In any event, the small liquid water droplets formed by condensation will not be capable of fully hydrating the coating and making the product ready to use by the conventional fast liquid activation.
It is possible to control the time for completing the hydration of the hydrophilic coating by selecting the degree of vapor permeability of the gas permeable, liquid impermeable barrier and, if used, the degree of vapor permeability of the “no-touch” catheter sleeve.
As also previously mentioned, the hydrating substance for activating the hydrophilic coating on the urinary catheter comprises water vapor (vapor phase water). The water vapor which is used to activate the hydrophilic coating is at least in part from water that previously had been liquid water resident in the second cavity. Thus, some of the quantity of water placed within the catheter package in its liquid phase may change phase to vapor and thus continuously replace water vapor lost from the gas phase as it enters and activates the hydrophilic coating.
A hydrophilic coating based on cross-linked polyvinylpyrollidone was created on the surface of a PVC tube. A CaCO3 filled polyethylene film (#728 from RKW, Belgium) was used as the gas permeable, liquid impermeable barrier separating the interior space formed by the catheter package into first and second cavities and a polyurethane film, designated as PT9300 from Deerfield Urethane, Deerfield, Mass., was used as the “no-touch” sleeve surrounding the coated tube. A wicking material made from an air laid hydrophilic polyester fabric with plastic netting laminated to both sides (available from DelStar Technologies Inc., Middleton Del.—designated as 4.5NPET-EE/EE) was placed in the second cavity, and wetted with more liquid phase water than required to provide sufficient vapor phase water for activating the coating. Then the second cavity was formed by sealing the polyethylene film to the package wall with the wicking material disposed therebetween. After forming the second cavity, the coated tube was placed onto the film outside the second cavity and the catheter package was sealed to form the first cavity. 96 hours after sealing the catheter package, the product was radiation sterilized.
After radiation sterilization, and after aging at room temperature for six weeks post package sealing, the coated tube was lubricious, and coefficient of friction testing indicated that the coated tube was now in a highly lubricious, ready to use state, with a fully functional, hydrated, lubricious coating.
Referring to
The liquid is confined to the second cavity 226b because of the liquid impermeable nature of the gas permeable, liquid impermeable barrier 228 which comprises a mid-package film or membrane. This film or membrane physically divides the interior space 226 into the two cavities 226a and 226b such that the hydrophilic coating cannot be hydrated until the liquid undergoes a phase change from a liquid to a vapor. However, after the liquid changes phase from a liquid to a vapor, the vapor in the second cavity 226b is then capable of passing from the second cavity 226b, through the gas permeable, liquid impermeable barrier 228, and into the first cavity 226a to serve as the hydrating substance. In particular, the vapor resulting from the phase change of the liquid passes into the first cavity 226a where it hydrates the hydrophilic coating to produce the low-friction surface on the catheter 222.
As an alternative, the gas permeable, liquid impermeable barrier 228 shown as a mid-package film or membrane in
Preferably, this alternative has the container formed as an elongated tube that will be substantially coextensive with at least the portion of the catheter 222 having the hydrophilic coating thereon so that as at least some of the quantity of liquid can change phase into a vapor and pass through the gas permeable, liquid impermeable barrier 228 from the second cavity 226b defined by the container into the first cavity containing the catheter 222 to activate the hydrophilic coating.
As with the embodiment of
As described in connection with the earlier embodiments, it will be noted in
As will be appreciated, when the end user opens the catheter package 224 by using the tear tape 256, it provides access to the catheter 222 because it opens the first sealed cavity 226a in which the catheter 222 is accommodated. Further, even after the catheter package 224 is opened in this manner, the second cavity 226b remains completely sealed. Thus, residual liquid still present in the second sealed cavity 226b of the catheter package 224 that has not changed phase to vapor is safely confined to the second cavity 226b and cannot spill on the end user.
The tear tape 256 will be understood to cause the catheter package 224 to tear along it to thereby cause the catheter package 224 to open along an intended opening line for access to the catheter 222 in the first sealed cavity 226a without opening the second sealed cavity 226b. The tear tape 256 thus extends within the first sealed cavity 226a in a desired direction relative to the catheter 222 to cause the catheter package 224 to open along the intended opening line in a manner facilitating removal of the catheter 222 from the package for use without opening the second sealed cavity 226b. The tear tape 256 can advantageously be adhesively or otherwise affixed to an inner surface of the catheter package 224 within the first sealed cavity 226a so as to extend generally from one end of the catheter package 224 to the other end thereof in a manner whereby it will be generally parallel to the catheter 222.
When the end user opens the catheter package 224, less of the original liquid will be present in the second cavity 226b as compared to the time of manufacture, because some of it will have changed phase to vapor. However, for remaining liquid, it is safely confined in the second cavity 226b. By taking advantage of vapor hydration of the hydrophilic coating and isolating the liquid in a sealed cavity even after removing the catheter from the package, there is no possibility of spillage.
While the vapor which passes from the second cavity 226b, through the gas permeable, liquid impermeable barrier 228, into the first cavity 226a may undergo some observable condensation within the first cavity, the liquid droplets which may be found in the first cavity resulting from such condensation will comprise, at most, a de minimis amount of liquid which will be far less than what would be required to produce liquid hydration of the hydrophilic coating on the catheter 222 and far less than what could possibly cause a spillage hazard.
Still referring to
Referring to
Referring to
In other words, the package 424 has a size and shape to accommodate the typical size and shape of a urine collection bag assembly such as 458, that may be made from, for example, a polyethylene or PVC material. Unlike the long, narrow shape of typical catheter-only packages such as 224 and 324, the catheter 422 is folded into a generally U-shape within the package 424, thereby requiring a shorter but wider package for the assembly due to the shape of the collection bag assembly 458. While not important to the packaging, it will be seen that the catheter 422 has a “no-touch” sleeve 423, an insertion tip 454, and a protective cap 456.
With regard to all of the aforementioned embodiments and features, it will be understood that they are useful for all catheter product packages regardless of the exact size and shape and whether or not they are formed to hold catheters alone or to hold urine collection bag assemblies that incorporate a catheter therein. Thus, it will also be seen from
The present disclosure is also directed to a method of making a ready-to-use catheter assembly comprising the step of providing a catheter package having an interior space divided by a gas permeable, liquid impermeable barrier into a first cavity and a second cavity. The method includes the step of placing a catheter having a hydrophilic coating on at least a part of its length into the first cavity. The method further includes the steps of placing a liquid into the catheter package in liquid isolation relative to the first cavity and confining the liquid for selective liquid flow communication with the second cavity.
The method still further includes the steps of delaying distribution, or at least use, of the catheter assembly for a period of time sufficient for i) the liquid to be placed into selective liquid flow communication with the second cavity, ii) at least some of the liquid to change phase into vapor within the second cavity, iii) at least some of the vapor to pass from the second cavity, through the gas permeable, liquid impermeable barrier, and into the first cavity, and iv) the vapor in the first cavity to hydrate the hydrophilic coating to produce a low-friction surface on the catheter, whereby the catheter assembly is ready-to-use.
In addition, the method may include the steps of i) providing the liquid in a rupturable container communicating with the second cavity, and ii) providing a wicking material in the second cavity to absorb the liquid after the rupturable container is breached. Further, the method may include the step of breaching the rupturable container after the catheter package has been sealed in order to permit the liquid to be released so it can be drawn into and absorbed by the wicking material. Still additionally, the method may include the step of sterilizing the catheter and the liquid after the catheter package has been sealed but before the rupturable container has been breached.
In connection with the foregoing, the method may also comprise providing the rupturable container for the liquid as a self-contained rupturable container placed within the second cavity in spaced relation to the wicking material and in spaced relation to one end of the catheter. Alternatively, the method may comprise providing the rupturable container for the liquid as a rupturable compartment in the catheter package for selective liquid flow communication with the second cavity through a rupturable seal in spaced relation to the wicking material.
In addition to the foregoing, the method may also include the steps of forming the structure and components of the various embodiments and arranging them in relation to one another in the manner described in detail hereinabove.
The method may include the steps of breaching the rupturable container to release the liquid so it can be drawn into and absorbed by the wicking material. Next, the method may include the step of severing the catheter package between the catheter and the rupturable following absorption of the liquid by the wicking material. The method may include the step of thereafter forming an end seal for the catheter package.
The method may include the step of breaching a rupturable seal to release the liquid so it can be drawn into and absorbed by the wicking material. It will be appreciated in connection with some embodiments which have been described in detail hereinabove (e.g.,
In connection with the foregoing description of the method relative to the embodiments illustrated in
In addition to the foregoing, the method may also include making and using a ready-to-use catheter assembly which comprises the step of providing the catheter package with a tear tape affixed to the first cavity to cause the catheter package to tear along the tear tape. The method may include the step of sealing the catheter package to form a sealed interior space in which the first cavity and second cavity are sealed. The catheter package can be sealed with the first and second cavities in liquid isolation. The method may also include the step of placing the liquid in sealed confinement in the second cavity in liquid isolation relative to the first cavity. Further, it may include the step of using the tear tape to open the first sealed cavity along an intended opening line for access to the catheter in the first cavity without opening the second cavity.
In addition, the method of making and using a ready-to-use catheter assembly may also include providing the tear tape to extend within the first cavity in a desired direction relative to the catheter to cause the catheter package to open along the intended opening line. This facilitates removal of the catheter from the catheter package for use without opening the second cavity. Finally, the method of making and using a ready-to-use catheter assembly may include affixing the tear tape to an inner surface of the catheter package within the first cavity to extend generally from one end of the catheter package to the other end generally parallel to the catheter.
While the foregoing sets forth a detailed description of the preferred disclosure, it will be appreciated by those skilled in the art that the details herein given may be varied without departing from the true spirit and scope of the disclosure as set forth in the appended claims.
This application is a non-provisional application claiming priority to U.S. Provisional Patent Application No. 60/988,920, filed on Nov. 19, 2007.
Number | Name | Date | Kind |
---|---|---|---|
2307736 | Clunan | Jan 1943 | A |
2360597 | Topolski | Oct 1944 | A |
2947415 | Garth | Aug 1960 | A |
3012481 | Hughes | Dec 1961 | A |
3035691 | Rasmussen et al. | May 1962 | A |
3286832 | Pilger | Nov 1966 | A |
3291377 | Eggen | Dec 1966 | A |
3345988 | Vitello | Oct 1967 | A |
3460529 | Leucci | Aug 1969 | A |
3556294 | Walck et al. | Jan 1971 | A |
3648704 | Jackson | Mar 1972 | A |
3651615 | Bohner et al. | Mar 1972 | A |
3736805 | Dent | Jun 1973 | A |
3854483 | Powers | Dec 1974 | A |
3861395 | Taniguchi | Jan 1975 | A |
3894540 | Bonner, Jr. | Jul 1975 | A |
3898993 | Taniguchi | Aug 1975 | A |
3930580 | Bazell et al. | Jan 1976 | A |
3934721 | Juster et al. | Jan 1976 | A |
3967728 | Gordon et al. | Jul 1976 | A |
4026296 | Stoy et al. | May 1977 | A |
4062363 | Bonner, Jr. | Dec 1977 | A |
4119094 | Micklus et al. | Oct 1978 | A |
4204527 | Wu et al. | May 1980 | A |
4230115 | Walz, Jr. et al. | Oct 1980 | A |
4248236 | Linder | Feb 1981 | A |
4269310 | Uson | May 1981 | A |
4290526 | Haiss | Sep 1981 | A |
4364478 | Tuns | Dec 1982 | A |
4379506 | Davidson | Apr 1983 | A |
4523919 | Focke et al. | Jun 1985 | A |
4652259 | O'Neil | Mar 1987 | A |
4754877 | Johansson et al. | Jul 1988 | A |
4772275 | Erlich | Sep 1988 | A |
4779727 | Taterka et al. | Oct 1988 | A |
4811847 | Reif et al. | Mar 1989 | A |
4838429 | Fabisiewicz et al. | Jun 1989 | A |
4863016 | Fong et al. | Sep 1989 | A |
4889523 | Sengewald | Dec 1989 | A |
4906237 | Johansson et al. | Mar 1990 | A |
4923061 | Trombley, III | May 1990 | A |
4925448 | Bazaral | May 1990 | A |
4927028 | Hemm et al. | May 1990 | A |
D311064 | Utas-Sjoberg et al. | Oct 1990 | S |
4993555 | Hemm | Feb 1991 | A |
5001884 | Hanagata et al. | Mar 1991 | A |
5038547 | Kai et al. | Aug 1991 | A |
D325526 | Deguchi et al. | Apr 1992 | S |
5105942 | van Veen et al. | Apr 1992 | A |
5147341 | Starke et al. | Sep 1992 | A |
5165540 | Forney | Nov 1992 | A |
5180591 | Magruder et al. | Jan 1993 | A |
5184771 | Jud et al. | Feb 1993 | A |
5203935 | May et al. | Apr 1993 | A |
5217114 | Gadberry et al. | Jun 1993 | A |
5226530 | Golden | Jul 1993 | A |
5242428 | Palestrant | Sep 1993 | A |
5322163 | Foos | Jun 1994 | A |
5328848 | Fong et al. | Jul 1994 | A |
5334166 | Palestrant | Aug 1994 | A |
5348678 | Hodam, Jr. et al. | Sep 1994 | A |
5356068 | Moreno | Oct 1994 | A |
5372254 | Gross | Dec 1994 | A |
5416131 | Wolff et al. | May 1995 | A |
5454798 | Kubalak et al. | Oct 1995 | A |
5470419 | Sasaki et al. | Nov 1995 | A |
5497601 | Gonzalez | Mar 1996 | A |
5501341 | Van Es | Mar 1996 | A |
5582342 | Jud | Dec 1996 | A |
5688459 | Mao et al. | Nov 1997 | A |
5800412 | Zhang et al. | Sep 1998 | A |
5836697 | Chiesa | Nov 1998 | A |
5848691 | Morris et al. | Dec 1998 | A |
5895374 | Rodsten | Apr 1999 | A |
5968069 | Dusbabek et al. | Oct 1999 | A |
D416477 | Flint | Nov 1999 | S |
6004305 | Hursman et al. | Dec 1999 | A |
6053313 | Farrell et al. | Apr 2000 | A |
6053905 | Daignault, Jr. et al. | Apr 2000 | A |
6059107 | Nøsted et al. | May 2000 | A |
6065597 | Pettersson et al. | May 2000 | A |
6098800 | Bennish, Jr. et al. | Aug 2000 | A |
6123712 | Di Caprio et al. | Sep 2000 | A |
6159227 | Di Caprio et al. | Dec 2000 | A |
6185907 | Malin et al. | Feb 2001 | B1 |
6228458 | Pinchen et al. | May 2001 | B1 |
6355004 | Pedersen et al. | Mar 2002 | B1 |
6391010 | Wilcox | May 2002 | B1 |
6403759 | Stamler et al. | Jun 2002 | B2 |
6409717 | Israelsson et al. | Jun 2002 | B1 |
6415921 | Ye et al. | Jul 2002 | B2 |
6457863 | Vassallo | Oct 2002 | B1 |
D467079 | Willows et al. | Dec 2002 | S |
6499278 | Cronauer et al. | Dec 2002 | B2 |
6506201 | Di Caprio et al. | Jan 2003 | B2 |
6578709 | Kavanagh et al. | Jun 2003 | B1 |
6602244 | Kavanagh et al. | Aug 2003 | B2 |
6634498 | Kayerød et al. | Oct 2003 | B2 |
6736805 | Israelsson et al. | May 2004 | B2 |
D491803 | Nestenborg | Jun 2004 | S |
6745545 | Schneider et al. | Jun 2004 | B2 |
D496266 | Nestenborg | Sep 2004 | S |
D497205 | Kubalak et al. | Oct 2004 | S |
D498671 | Nestenborg et al. | Nov 2004 | S |
D498672 | Nestenborg et al. | Nov 2004 | S |
D499016 | Nestenborg et al. | Nov 2004 | S |
D499017 | Nestenborg et al. | Nov 2004 | S |
D499335 | Nestenborg et al. | Dec 2004 | S |
D499643 | Nestenborg et al. | Dec 2004 | S |
6848574 | Israelsson et al. | Feb 2005 | B1 |
6848591 | Kiel et al. | Feb 2005 | B2 |
D503335 | Risberg et al. | Mar 2005 | S |
6884206 | Lasson et al. | Apr 2005 | B2 |
D505067 | Nestenborg et al. | May 2005 | S |
6887230 | Kubalak et al. | May 2005 | B2 |
6974032 | Intini et al. | Dec 2005 | B2 |
6996952 | Gupta et al. | Feb 2006 | B2 |
7087048 | Israelsson et al. | Aug 2006 | B2 |
7311698 | Tanghoj et al. | Dec 2007 | B2 |
7334679 | Givens, Jr. | Feb 2008 | B2 |
7380658 | Murray et al. | Jun 2008 | B2 |
7476223 | McBride | Jan 2009 | B2 |
7615045 | Israelsson et al. | Nov 2009 | B2 |
7770726 | Murray et al. | Aug 2010 | B2 |
20010001443 | Kayerod et al. | May 2001 | A1 |
20010054562 | Pettersson et al. | Dec 2001 | A1 |
20020068180 | Yang et al. | Jun 2002 | A1 |
20030008042 | Khalsa et al. | Jan 2003 | A1 |
20030018322 | Tanghoj et al. | Jan 2003 | A1 |
20030034264 | Hamai et al. | Feb 2003 | A1 |
20030035868 | Coulter et al. | Feb 2003 | A1 |
20030132128 | Mazur | Jul 2003 | A1 |
20030168365 | Kaern | Sep 2003 | A1 |
20030174909 | Parra | Sep 2003 | A1 |
20040074794 | Conway et al. | Apr 2004 | A1 |
20040136623 | Obara | Jul 2004 | A1 |
20040142074 | Hentzel et al. | Jul 2004 | A1 |
20040153051 | Israelsson et al. | Aug 2004 | A1 |
20050003155 | Huffer | Jan 2005 | A1 |
20050015076 | Giebmeyer et al. | Jan 2005 | A1 |
20050070882 | McBride | Mar 2005 | A1 |
20050109648 | Kerzman et al. | May 2005 | A1 |
20050137582 | Kull-Osterlin et al. | Jun 2005 | A1 |
20050194276 | Lubs et al. | Sep 2005 | A1 |
20060163097 | Murray et al. | Jul 2006 | A1 |
20060263404 | Nielsen et al. | Nov 2006 | A1 |
20070289887 | Murray et al. | Dec 2007 | A1 |
20080260576 | Bruun et al. | Oct 2008 | A1 |
20090131917 | Kavanagh et al. | May 2009 | A1 |
Number | Date | Country |
---|---|---|
706432 | Jun 1999 | AU |
677094 | Apr 1991 | CH |
1106744 | Aug 1995 | CN |
197 409 | Aug 1979 | CZ |
2 317 839 | Oct 1974 | DE |
10 324 012 | Dec 2004 | DE |
102396 | Aug 1965 | DK |
122496 | Mar 1998 | DK |
0 217 771 | Apr 1987 | EP |
0 440 427 | Aug 1991 | EP |
0 492 399 | Jul 1992 | EP |
0 521 618 | Jan 1993 | EP |
0 586 324 | Mar 1994 | EP |
0 677 299 | Oct 1995 | EP |
0 680 895 | Nov 1995 | EP |
0 680 896 | Nov 1995 | EP |
0 685 179 | Dec 1995 | EP |
0 957 043 | Nov 1999 | EP |
0 959 021 | Nov 1999 | EP |
1 095 856 | May 2001 | EP |
1 115 450 | Jul 2001 | EP |
1 120 355 | Aug 2001 | EP |
1145729 | Oct 2001 | EP |
1 262 425 | Dec 2002 | EP |
1 346 917 | Sep 2003 | EP |
1 447 345 | Aug 2004 | EP |
1 642 610 | Apr 2006 | EP |
1 642 611 | Apr 2006 | EP |
1 647 298 | Apr 2006 | EP |
1 809 345 | Jul 2007 | EP |
1 465 544 | Feb 1977 | GB |
1 600 963 | Oct 1981 | GB |
2 235 680 | Mar 1991 | GB |
2 284 764 | Jun 1995 | GB |
2 334 315 | Aug 1999 | GB |
2 404 916 | Feb 2005 | GB |
49-132888 | Nov 1974 | JP |
55-012265 | Jan 1980 | JP |
9600276-1 | Jan 1996 | SE |
WO-8606284 | Nov 1986 | WO |
WO-9303777 | Mar 1993 | WO |
WO-9406377 | Mar 1994 | WO |
WO-9416747 | Aug 1994 | WO |
WO-9630277 | Oct 1996 | WO |
WO-9726937 | Jul 1997 | WO |
WO-9739697 | Oct 1997 | WO |
WO-9806642 | Feb 1998 | WO |
WO-9811932 | Mar 1998 | WO |
WO-9819729 | May 1998 | WO |
WO-9858988 | Dec 1998 | WO |
WO-9942155 | Aug 1999 | WO |
WO-0016843 | Mar 2000 | WO |
WO-0030696 | Jun 2000 | WO |
WO-0152763 | Jul 2001 | WO |
WO-03008029 | Jan 2003 | WO |
WO-03064279 | Aug 2003 | WO |
WO-03093357 | Nov 2003 | WO |
WO-2004056909 | Jul 2004 | WO |
WO 2005014055 | Feb 2005 | WO |
WO-2006037321 | Apr 2006 | WO |
Entry |
---|
European Search Report issued in counterpart European Patent Application No. 08103085.0 (7 pages), Aug. 12, 2008. |
“LoFric®: The Leading Low Friction, Low Risk Catheter,” AstraTech (2006). |
“The LoFric Story,” AstraTech (2006). |
Ikada et al., “Lubricating Polymer Surfaces,” Research Center for Biomedical Engineering, Kyoto University, pp. 58-60 (1993). |
Kelly et al. “Prolonging the Life of the Hydrophilic-Conted Catheter,” British Journal of Urology, 79 (Suppl. 4):12 (1997). |
Moore, “Intermittent Self-Catheterisation: Research-Based Practice,” British Journal of Nursing, 4(18):1057 (1995). |
O'Neil, “At Last: A System Which Addresses All the Issues of Nosocomial U.T.I. Associated with Catheterization,” Nursing Times, 33:88-90 (1986). |
Tidd et al., “Comparison of Hydrophilic Polymer-Coated Latex, Uncoated Latex and PVC Indwelling Balloon Catheters in the Prevention of Urinary Infection,” British Journal of Urolog. 48:285-291 (1976). |
International Search Report for Application No. PCT/US04/25417, dated Feb. 9, 2005. |
International Search Report for Application No. PCT/US07/70783, dated Mar. 31, 2008. |
Office Action for U.S. Appl. No. 11/760,545, dated Dec. 29, 2009. |
Office Action for U.S. Appl. No. 11/760,545, dated Feb. 25, 2009. |
Office Action for U.S. Appl. No. 11/760,545, dated May 21, 2009. |
Office Action for U.S. Appl. No. 12/852,959, dated Jan. 7, 2011. |
Office Action for U.S. Appl. No. 12/852,959, dated Sep. 14, 2010. |
Written Opinion for Application No. PCT/US04/25417, dated Feb. 9, 2005. |
Written Opinion for Application No. PCT/US07/70783, dated Mar. 31, 2008. |
European Search Report for Application No. EP11150068.2, dated Mar. 7, 2011. |
European Search Report for Application No. EP11150060.9, dated Mar. 8, 2011. |
Patent Examination Report No. 1 for Australian Patent Application No. 2008/203536 dated Feb. 4, 2013. |
Number | Date | Country | |
---|---|---|---|
20090131917 A1 | May 2009 | US |
Number | Date | Country | |
---|---|---|---|
60988920 | Nov 2007 | US |